Compare
NewGenIvf Group Ltd vs Cryo Cell International Inc vs Mangoceuticals, Inc. vs Pacific Health Care Organization Inc
| Latest fiscal year | NewGenIvf Group Ltd NIVFRevenue covers only part of its income (partial revenue) | Cryo Cell International Inc CCEL | Mangoceuticals, Inc. MGRX | Pacific Health Care Organization Inc PFHO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-11-30 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $31.57M | $456.0K | $6.72M |
| Revenue growth (YoY) | n/a | -1.3% | -26.0% | +10.7% |
| Gross margin | n/a | 76.6% (computed) | 54.9% | n/a |
| Operating margin | n/a | 1.5% | n/m | 14.9% |
| Net margin | n/a | -7.7% | n/m | 20.7% |
| Net income | $9.88M | -$2.43M | -$20.64M | $1.39M |
| EPS (Diluted) | $3.04 | -$0.30 | -$2.17 | $0.11 |
| Operating cash flow | -$10.93M | $5.48M | -$5.85M | $1.16M |
| Free cash flow | -$11.06M | $5.25M | n/a | $1.14M |
| Cash & equivalents | $758.6K | $319.0K | $1.49M | $2.17M |
| Total assets | $32.72M | $61.73M | $16.09M | $13.46M |
| Total liabilities | $6.74M | $80.33M | $890.6K | n/a |
| Shareholders' equity | $25.99M | -$18.61M | $15.20M | $13.07M |
| Return on year-end equity | 38.0% | n/a | -135.8% | 10.6% |
| Shares outstanding | 240.6K | 8.06M | 15.89M | 12.80M |
Revenue, most recent five fiscal years
| Fiscal year | NewGenIvf Group Ltd | Cryo Cell International Inc | Mangoceuticals, Inc. | Pacific Health Care Organization Inc |
|---|---|---|---|---|
| Latest | n/a | $31.57M Ended 2025-11-30 | $456.0K Ended 2025-12-31 | $6.72M Ended 2025-12-31 |
| 1 year earlier | n/a | $31.99M Ended 2024-11-30 | $615.9K Ended 2024-12-31 | $6.07M Ended 2024-12-31 |
| 2 years earlier | n/a | $31.34M Ended 2023-11-30 | $731.5K Ended 2023-12-31 | $5.63M Ended 2023-12-31 |
| 3 years earlier | n/a | $30.34M Ended 2022-11-30 | $8.9K Ended 2022-12-31 | $5.74M Ended 2022-12-31 |
| 4 years earlier | n/a | $28.88M Ended 2021-11-30 | n/a | $5.40M Ended 2021-12-31 |